Article Details
Retrieved on: 2021-06-15 06:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
June 15 (Reuters) - Anglo-Swedish drugmaker AstraZeneca said on Tuesday a study of its monoclonal antibody treatment, AZD7442, did not meet the ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here